Аналитика NYSE на 9 сентября

Спайдер повышается перед открытием торгов на NYSE.

Европейские индексы на положительной территории.

SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 166.20 Поддержка: 166.60
ПремаркетNYSE/NASDAQ:
Gapping up:

In reaction to strong earnings/guidance/SSS: MNDL +14.1%, SSL +1%, YUM +0.9%, .
M&A news: COGO +14.4% (signs letter of intent for Chairman and CEO Jeffrey Kang to acquire 30.4%), LCC +1.8% (cont volatility on merger related spec), SFD +0.8% (Smithfield Foods and Shuanghui International receive CFIUS clearance), MOLX SHARES HALTED (to Be Acquired by Koch Industries for $38.50 Per Share in Cash (29.34 settlement)).
Select fertilizerrelated names showing strength: IPI +4.6%, MOS +2.8%, POT +2.3%.
Select metals/mining stocks trading higher (strong China trade data): HMY +4.6%, VALE +1.9%, BHP +1.6%, RIO +1.6%, KWK +1.2%, FCX +1.2%.
Select solar related names showing strength:
SOL +5.8%, JKS +1.7%, FSLR +1.2%, YGE +1.1%.
Other news: UNIS +22.1% (signs long-term supply contract with Sanofi), ONCY +19.2% (positive final tumour response data for U.S. Phase 2 study of REOLYSIN in squamous cell lung cancer), BLRX +12.9% (BL-8040 receives Orphan Drug Designation for treatment of AML), ISIS +8.7% (announce strategic collaboration with Biogen to advance treatment of neurological disorders ), ASTC +6.3% (awarded contract to provide facilities and pre-launch processing services for the Magnetospheric MultiScale mission to launch in late 2014), NBG +5% (still checking), DAL +4.6% ( set to join the S&P 500, replacing BMC Software), CCI +2.8% (announced intention to convert to a REIT), ALU +2.5% (cont strength from last week), NOK +2.2% (cont strength from last week), SNY +2.2% (still checking), FENG +1.9% (announces appointment of Betty Yip Ho as CFO), AMD +1.7% (still checking), AAPL +1.4% (cont strength following Friday's late headlines that co plans to ship lower cost iPhone to CHL), FB +1.1% (NYTimes discusses two additional search tools at FB).
Analyst comments: BRCD +2.8% (upgraded to Outperform from Sector Perform at RBC Capital Markets), EXPE +2.7% (upgraded to Buy from Neutral at Lazard), LFL +2.6% (upgraded to Strong Buy from Outperform at Raymond James), MDC +2.4% (upgraded to Neutral from Sell at Citigroup), TPRE +2.3% (initiated with a Overweight at Morgan Stanley ), ZQK +2.2% (upgraded to Outperform from Neutral at Credit Suisse), IPAR +2.2% (upgraded to Buy at B. Riley), BTI +1.4% (upgraded to Buy from Neutral at BofA/Merrill), NTAP +0.9% (upgraded to Buy from Neutral at UBS).

Gapping down:

In reaction to disappointing earnings/guidance: SHFL -1.0.
Select oil/gas related names showing early weakness: E -1.3%, RDS.A -0.9%, BP -0.5%, TOT -0.5%.
Other news: BIOD -5.6% (achieves primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog), SCTY -2% ( files for 3,674,565 share offering by holders), SNE -2% (plans to introduce PS4 on Feb 22, according to reports), TSLA -1.4% (still checking), GSK -0.7% (reaches agreement to divest Lucozade and Ribena for EUR 1.35 bln; also China bribery allegations have been added to GSK probe, according to reports).
Analyst comments: ROC -1.4% (downgraded to Hold from Buy at Deutsche Bank).

Интересные новостные акции NYSEи NASDAQ: